Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Pain 2Neoplasms 2Weight Loss 1Trigger Finger Disorder 1Prostatic Neoplasms 1Pituitary Neoplasms 1Patient Satisfaction 1Nose Neoplasms 1Mucositis 1Menorrhagia 1Median Neuropathy 1Lymphoma, Follicular 1Leiomyoma 1Hemorrhage 1Head and Neck Neoplasms 1Ganglion Cysts 1Esthesioneuroblastoma, Olfactory 1De Quervain Disease 1Cognitive Dysfunction 1Cachexia 1Adenomyosis 1Abnormalities, Radiation-Induced 1

Interventions

oxycodone-acetaminophen 1cyclohexaneacetic acid 1acetaminophen, hydrocodone drug combination 1Pain Management 1Methods 1Ibuprofen 1Gabapentin 1Fentanyl 1Educational Status 1Early Intervention, Educational 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Abnormalities, Radiation-Induced × Ibuprofen × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡